PCVX – vaxcyte, inc. (US:NASDAQ)
Stock Stats
News
RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board [Yahoo! Finance]
Mammalian Cell Fermentation Technology Market anticipated journey towards the lucrative US$ 68 Billion valuation. At a CAGR of 10% by 2034 | Future Market Insights, Inc. [Yahoo! Finance]
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $95.00 price target on the stock.
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst [Seeking Alpha]
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
Form 4 Vaxcyte, Inc. For: May 01 Filed by: Eydelman Mikhail
Form 4 Vaxcyte, Inc. For: May 01 Filed by: Wassil Jim
Form 4 Vaxcyte, Inc. For: May 01 Filed by: PICKERING GRANT
Form 144 Vaxcyte, Inc. Filed by: Wassil Jim
Form 144 Vaxcyte, Inc. Filed by: PICKERING GRANT
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.